Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 15 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2016Weight-loss outcomes: A systematic review and meta-analysis of intermittent energy restriction trials lasting a minimum of 6 monthsHeadland, M.; Clifton, P.M.; Carter, S.; Keogh, J.B.
2016Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACSKhazanie, P.; Hammill, B.G.; Patel, C.B.; Kiernan, M.S.; Cooper, L.B.; Arnold, S.V.; Fendler, T.J.; Spertus, J.A.; Curtis, L.H.; Hernandez, A.F.
2019Phase I trial of inducible caspase 9 T cells in adult stem cell transplant demonstrates massive clonotypic proliferative potential and long-term persistence of transgenic TcellsZhang, P.; Raju, J.; Ullah, M.A.; Au, R.; Varelias, A.; Gartlan, K.H.; Olver, S.D.; Samson, L.D.; Sturgeon, E.; Zomerdijk, N.; Avery, J.; Gargett, T.; Brown, M.P.; Coin, L.J.; Ganesamoorthy, D.; Hutchins, C.; Pratt, G.R.; Kennedy, G.A.; James Morton, A.; Curley, C.I.; et al.
2014Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trialChow, E.; Meyer, R.; Chen, B.; van der Linden, Y.; Roos, D.; Hartsell, W.; Hoskin, P.; Wu, J.; Nabid, A.; Tissing-Tan, C.; Oei, B.; Babington, S.; Demas, W.; Wilson, C.; Wong, R.; Brundage, M.
2012Move more for life: the protocol for a randomised efficacy trial of a tailored-print physical activity intervention for post-treatment breast cancer survivorsShort, C.E.; James, E.L.; Girgis, A.; Mcelduff, P.; Plotnikoff, R.C.
2013Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesCho, Y.; Badve, S.; Hawley, C.; McDonald, S.; Brown, F.; Boudville, N.; Bannister, K.; Clayton, P.; Johnson, D.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2010Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.